Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/180396
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found in about 10% of patients with critical COVID-19 pneumonia, but not in subjects with asymptomatic infections. We detect auto-Abs neutralizing 100-fold lower, more physiological, concentrations of IFN-α and/or -ω (100 pg/mL, in 1/10 dilutions of plasma) in 13.6% of 3,595 patients with critical COVID-19, including 21% of 374 patients > 80 years, and 6.5% of 522 patients with severe COVID-19. These antibodies are also detected in 18% of the 1,124 deceased patients (aged 20 days-99 years; mean: 70 years). Moreover, another 1.3% of patients with critical COVID-19 and 0.9% of the deceased patients have auto-Abs neutralizing high concentrations of IFN-β. We also show, in a sample of 34,159 uninfected subjects from the general population, that auto-Abs neutralizing high concentrations of IFN-α and/or -ω are present in 0.18% of individuals between 18 and 69 years, 1.1% between 70 and 79 years, and 3.4% >80 years. Moreover, the proportion of subjects carrying auto-Abs neutralizing lower concentrations is greater in a subsample of 10,778 uninfected individuals: 1% of individuals <70 years, 2.3% between 70 and 80 years, and 6.3% >80 years. By contrast, auto-Abs neutralizing IFN-β do not become more frequent with age. Auto-Abs neutralizing type I IFNs predate SARS-CoV-2 infection and sharply increase in prevalence after the age of 70 years. They account for about 20% of both critical COVID-19 cases in the over-80s, and total fatal COVID-19 cases.
Matèries
Matèries (anglès)
Citació
Col·leccions
Articles publicats en revistes (Ciències Clíniques)
<b>Publicacions de projectes de recerca finançats per la UE</b>
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
<b>Publicacions de projectes de recerca finançats per la UE</b>
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Citació
BASTARD, Paul, Danish Blood Donor Study, Danish CHGE, RIGO BONNIN, Raúl, HGID Lab University of Hong Kong, Amsterdam UMC Covid-19 Biobank Investigators, St. James’s Hospital SARS CoV2 Interest group, PLANAS OBRADORS, Anna m., CONSTANCES Cohort, COVID Human Genetic Effort, SOLANICH, Xavier, 3C-Dijon Study, Milieu Intérieur Consortium, Cerba HealthCare, MORANDEIRA-REGO, Francisco, Etablissement du Sang study group, NIAID Immune Response To Covid Group, COVID-STORM Clinicians University of Hong Kong, NH-COVAIR Study Group, PUJOL ONOFRE, Aurora, French COVID Cohort Study Group, CoV-Contact Cohort, Imagine COVID Group, CASASNOVAS PONS, Carlos, JORDÁN GARCÍA, Iolanda. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. _Science Immunology_. 2021. Vol. 6, núm. 62. [consulta: 24 de gener de 2026]. ISSN: 2470-9468. [Disponible a: https://hdl.handle.net/2445/180396]